Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Chen, Guojun ^a   Wang, Yali ^a   Xu, Zhenyu ^b   Fang, Feng ^a   Xu, Renmei ^a   Wang, Yue ^b   Hu, Xiaoli ^b   Fan, Lixing ^b   Liu, Houqi ^b  

^a Hospital of Zhejiang General Corps of Armed Police Forces   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Autologous transplantation; Bone marrow mesenchymal stem cells; Cell therapy; Cerebral palsy; Neural stem cell like cells

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL FUNCTION; CELL TRANSPLANTATION; CELL TYPE; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GROSS MOTOR FUNCTION MEASURE; HUMAN; IMMUNOREGULATION; LANGUAGE ABILITY; MALE; MESENCHYMAL STEM CELL; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NEURAL STEM CELL LIKE CELL; OPEN STUDY; PRESCHOOL CHILD; REHABILITATION CARE; SAFETY; SCHOOL CHILD; SCORING SYSTEM; SUBARACHNOID SPACE; SURVIVAL; TISSUE REPAIR;

ADOLESCENT; ADULT; BONE AND BONES; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MESENCHYMAL STROMAL CELLS; MOTOR ACTIVITY; NEURAL STEM CELLS; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84872803291     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-21     Document Type: Article

References (37)

1. An T, Guo XQ, Pu XH. Study progress in early intervention of high- risk infants for the prevention and treatment of cerebral palsy. Clin Pediatr 2006, 24:696-698.
2. Moster D, Lie RT, Markestad T. Long-term medical and social consequences of preterm birth. N Engl J Med 2008, 359:262-273. 10.1056/NEJMoa0706475, 18635431.
3. Hu YM. Jiang ZF 2002, Zhu FT: Practice of pediatrics. People's medical publishing house.
4. Yeargin-Allsopp M, Van Naarden Braun K, Doernberg NS, Benedict RE, Kirby RS, Durkin MS. Prevalence of cerebral palsy in 8-year-old children in three areas of the United States in 2002: a multisite collaboration. Pediatrics 2008, 121:547-554. 10.1542/peds.2007-1270, 18310204.
5. Koman LA, Smith BP, Shilt JS. Cerebral palsy. Lancet 2004, 363:1619-1631. 10.1016/S0140-6736(04)16207-7, 15145637.
6. Holt RL, Mikati MA. Care for child development: basic science rationale and effects of interventions. Pediatr Neurol 2011, 44:239-253. 10.1016/j.pediatrneurol.2010.11.009, 21397164.
7. Luan Z, Yin GC, Hu XH, Qu SQ, Wu NH, Yan FQ, Qian YM, Jin HY, Gong XJ. [Treatment of an infant with severe neonatal hypoxic-ischemic encephalopathy sequelae with transplantation of human neural stem cells into cerebral ventricle]. Zhonghua Er Ke Za Zhi 2005, 43:580-583. discussion 580.
8. Chen GJ, Fang F, Tang YH. Cell Therapy of cerebral diseases in China: a meta-analysis. Med J Chin PAPF 2011, 22:216-218.
9. Carroll JE, Mays RW. Update on stem cell therapy for cerebral palsy. Expert Opin Biol Ther 2011, 11:463-471. 10.1517/14712598.2011.557060, 3057381, 21299445.
10. Trounson A, Thakar RG, Lomax G, Gibbons D. Clinical trials for stem cell therapies. BMC Med 2011, 9:52. 10.1186/1741-7015-9-52, 3098796, 21569277.
11. Du K, Luan Z, Qu SQ. Clinical outcome of bone marrow mesenchymal stem cells transplantation in children with severe cerebral palsy. Clin Pediatr 2011, 29:55-58.
12. Wang XD, Yang J, Li M. Effects of bone marrow mesenchymal stem cell graft on gross motor function in children with cerebral. Journal of China-Japan Friendship Hospital 2010, 24:337-342.
13. Bartley J, Carroll JE. Stem cell therapy for cerebral palsy. Expert Opin Biol Ther 2003, 3:541-549.
14. Long X, Olszewski M, Huang W, Kletzel M. Neural cell differentiation in vitro from adult human bone marrow mesenchymal stem cells. Stem Cells Dev 2005, 14:65-69. 10.1089/scd.2005.14.65, 15725745.
15. Hermann A, Gastl R, Liebau S, Popa MO, Fiedler J, Boehm BO, Maisel M, Lerche H, Schwarz J, Brenner R, Storch A. Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells. J Cell Sci 2004, 117:4411-4422. 10.1242/jcs.01307, 15304527.
16. Deng J, Petersen BE, Steindler DA, Jorgensen ML, Laywell ED. Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation. Stem Cells 2006, 24:1054-1064. 10.1634/stemcells.2005-0370, 16322639.
17. Zhao ZM, Li HJ, Liu HY, Lu SH, Yang RC, Zhang QJ, Han ZC. Intraspinal transplantation of CD34+ human umbilical cord blood cells after spinal cord hemisection injury improves functional recovery in adult rats. Cell Transplant 2004, 13:113-122.
18. Enzmann GU, Benton RL, Talbott JF, Cao Q, Whittemore SR. Functional considerations of stem cell transplantation therapy for spinal cord repair. J Neurotrauma 2006, 23:479-495. 10.1089/neu.2006.23.479, 16629631.
19. Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Nasuelli N, Oggioni GD, Testa L, Fagioli F. Stem cell treatment in Amyotrophic Lateral Sclerosis. J Neurol Sci 2008, 265:78-83. 10.1016/j.jns.2007.05.016, 17582439.
20. Mazzini L, Ferrero I, Luparello V, Rustichelli D, Gunetti M, Mareschi K, Testa L, Stecco A, Tarletti R, Miglioretti M, et al. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. Exp Neurol 2010, 223:229-237. 10.1016/j.expneurol.2009.08.007, 19682989.
21. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317. 10.1080/14653240600855905, 16923606.
22. Lundkvist Josenby A, Jarnlo GB, Gummesson C, Nordmark E. Longitudinal construct validity of the GMFM-88 total score and goal total score and the GMFM-66 score in a 5-year follow-up study. Phys Ther 2009, 89:342-350. 10.2522/ptj.20080037, 19220999.
23. Back SA, Craig A, Luo NL, Ren J, Akundi RS, Ribeiro I, Rivkees SA. Protective effects of caffeine on chronic hypoxia-induced perinatal white matter injury. Ann Neurol 2006, 60:696-705. 10.1002/ana.21008, 17044013.
24. Back SA, Craig A, Kayton RJ, Luo NL, Meshul CK, Allcock N, Fern R. Hypoxia-ischemia preferentially triggers glutamate depletion from oligodendroglia and axons in perinatal cerebral white matter. J Cereb Blood Flow Metab 2007, 27:334-347. 10.1038/sj.jcbfm.9600344, 16757980.
25. Prasad R, Verma N, Srivastava A, Das BK, Mishra OP. Magnetic resonance imaging, risk factors and co-morbidities in children with cerebral palsy. J Neurol 2011, 258:471-478. 10.1007/s00415-010-5782-2, 20953790.
26. Park KI, Himes BT, Stieg PE, Tessler A, Fischer I, Snyder EY. Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: Evidence from engraftment of Neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury. Exp Neurol 2006, 199:179-190. 10.1016/j.expneurol.2006.03.016, 16714016.
27. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007, 25:2739-2749. 10.1634/stemcells.2007-0197, 17656645.
28. Iwanami A, Kaneko S, Nakamura M, Kanemura Y, Mori H, Kobayashi S, Yamasaki M, Momoshima S, Ishii H, Ando K, et al. Transplantation of human neural stem cells for spinal cord injury in primates. J Neurosci Res 2005, 80:182-190. 10.1002/jnr.20436, 15772979.
29. Ma H, Yu B, Kong L, Zhang Y, Shi Y. Neural stem cells over-expressing brain-derived neurotrophic factor (BDNF) stimulate synaptic protein expression and promote functional recovery following transplantation in rat model of traumatic brain injury. Neurochem Res 2012, 37:69-83. 10.1007/s11064-011-0584-1, 21901549.
30. Hofstetter CP, Holmstrom NA, Lilja JA, Schweinhardt P, Hao J, Spenger C, Wiesenfeld-Hallin Z, Kurpad SN, Frisen J, Olson L. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci 2005, 8:346-353. 10.1038/nn1405, 15711542.
31. Lim JY, Park SI, Kim SM, Jun JA, Oh JH, Ryu CH, Jeong CH, Park SH, Park SA, Oh W, et al. Neural Differentiation of Brain-derived Neurotrophic Factor-expressing Human Umbilical Cord Blood-derived Mesenchymal Stem Cells in Culture via TrkB-mediated ERK and beta-catenin Phosphorylation and following Transplantation into the Developing Brain. Cell Transplant 2011, 20:1855-1866.
32. Chekhonin VP, Lebedev SV, Volkov AI, Pavlov KA, Ter-Arutyunyants AA, Volgina NE, Savchenko EA, Grinenko NF, Lazarenko IP. Activation of expression of brain-derived neurotrophic factor at the site of implantation of allogenic and xenogenic neural stem (progenitor) cells in rats with ischemic cortical stroke. Bull Exp Biol Med 2011, 150:515-518. 10.1007/s10517-011-1180-8, 22268055.
33. Momin EN, Mohyeldin A, Zaidi HA, Vela G, Quinones-Hinojosa A. Mesenchymal stem cells: new approaches for the treatment of neurological diseases. Curr Stem Cell Res Ther 2010, 5:326-344. 10.2174/157488810793351631, 20528757.
34. Centeno CJ, Schultz JR, Cheever M, Freeman M, Faulkner S, Robinson B, Hanson R. Safety and complications reporting update on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr Stem Cell Res Ther 2011, 6:368-378. 10.2174/157488811797904371, 22023622.
35. Tan J, Wu W, Xu X, Liao L, Zheng F, Messinger S, Sun X, Chen J, Yang S, Cai J, et al. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA 2012, 307:1169-1177. 10.1001/jama.2012.316, 22436957.
36. Parkes J, Hill N, Platt MJ, Donnelly C. Oromotor dysfunction and communication impairments in children with cerebral palsy: a register study. Dev Med Child Neurol 2010, 52:1113-1119. 10.1111/j.1469-8749.2010.03765.x, 20813020.
37. Pennington L, Miller N, Robson S, Steen N. Intensive speech and language therapy for older children with cerebral palsy: a systems approach. Dev Med Child Neurol 2010, 52:337-344. 10.1111/j.1469-8749.2009.03366.x, 19758364.